Assessment of human papilloma virus-related disease
Abstract
A method for detecting induced HPV infected with HPV patient comprising the steps of cellular transformation: - measuring at least two levels of mRNAs expressed HPV from a sample collected from said patient, wherein said mRNAs They comprise a first RNA selected from the group consisting of E6 mRNA and E7 mRNA and a second RNA selected from the group consisting of E2 mRNA and L1 mRNA; - Determining expression level of E6 and / or E7 and expression level of E2 and / or L1 such that a ratio of E6 and / or E7 is determined to L1 and / or E2, wherein a ratio greater than 2 it is indicative of HPV-induced cell transformation risk of neoplasia.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
40 members in 13 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 6942697 | United States of America | P | |
| 7048698 | United States of America | P | |
| 8216798 | United States of America | P | |
| 9826447 | United States of America | W |
Members40
| Document | Office | Kind | |
|---|---|---|---|
| CA2313483A1 | Canada | A1 | |
| WO9929890A2 | World Intellectual Property Organization (WIPO) | A2 | |
| CA2313641A1 | Canada | A1 | |
| WO9931273A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU1911799A | Australia | A | |
| AU1723299A | Australia | A | |
| WO9929890A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO9931273A3 | World Intellectual Property Organization (WIPO) | A3 | |
| NO20002979D0 | Norway | D0 | |
| NO20002980D0 | Norway | D0 | |
| NO20002980L | Norway | L | |
| NO20002979LThis record | Norway | L | |
| EP1038022A2 | European Patent Office (EPO) | A2 | |
| EP1038029A2 | European Patent Office (EPO) | A2 | |
| BR9814272A | Brazil | A | |
| BR9814271A | Brazil | A | |
| JP2001526045A | Japan | A | |
| US6355424B1 | United States of America | B1 | |
| JP2002508190A | Japan | A | |
| AU746061B2 | Australia | B2 | |
| AU748022B2 | Australia | B2 | |
| US2002127545A1 | United States of America | A1 | |
| US2003091992A1 | United States of America | A1 | |
| EP1038022B1 | European Patent Office (EPO) | B1 | |
| AT299946T | Austria | T | |
| ATE299946T1 | Austria | T1 | |
| DE69830927D1 | Germany | D1 | |
| DK1038022T3 | Denmark | T3 | |
| US6969585B2 | United States of America | B2 | |
| PT1038022E | Portugal | E | |
| ES2246546T3 | Spain | T3 | |
| AU2002300070B2 | Australia | B2 | |
| DE69830927T2 | Germany | T2 | |
| US2007154884A1 | United States of America | A1 | |
| US7291455B2 | United States of America | B2 | |
| JP2010136729A | Japan | A | |
| US7879546B2 | United States of America | B2 | |
| US2011097708A1 | United States of America | A1 | |
| NO330906B1 | Norway | B1 | |
| CA2313483C | Canada | C |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Patent expiredExpiredMK1K | MK1K |
Numbers
- Application
- 2979
Titles2
- English
- Investigation of human papillomavirus-related disease
- Norwegian
- Undersøkelse av human papillomavirus-relatert sykdom
Classification
- CPC, 6
- C12Q1/708
- C12Q1/6806
- C12Q1/6886
- C12Q2600/112
- C12Q2600/118
- A01N1/122
- IPC, 9
- A01N1 02
- C07K14 025
- C12N15 09
- C12M1 00
- C12Q1 00
- C12Q1 68
- C12Q1 70
- G01N33 48
- G01N33 50